Report Scope:
This research report categorizes the anti-Parkinson’s drugs market by type. Product types include low dopaminergic, dopamine agonists, enzyme inhibitors and other anti-Parkinson’s medications.
Report Includes:
- 95 data tables
- An overview of the global market for anti-Parkinson’s drugs and their future demand
- Analyses of global market trends, with data from 2013-2017, and projections of compound annual growth rates (CAGRs) through 2022
- Analyses of the major factors and technological advances such as biomarkers, 3D printed drugs, mobile applications and wearable technologies in the monitoring and treatment of Parkinson’s disease
- Discussion of the major segments of the anti-Parkinson’s drugs, i.e., dopaminergic drugs, dopamine agonists, enzyme inhibitors and other anti-Parkinson’s medications
- Company profiles of the major players in the market, including AbbVie, Mylan Laboratories, Valeant Pharmaceuticals and Novartis
Key Highlights:
- The global anti-Parkinson’s drugs market should reach $5.7 billion by 2022 from $4.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.1%, from 2017 to 2022.
- Asia Pacific anti-Parkinson’s drugs market is expected to grow from $1.0 billion in 2017 to $1.4 billion in 2022 at a CAGR of 6.4% for the period 2017-2022.
- North American anti-Parkinson’s drugs market is expected to grow from $1.3 billion in 2017 to $1.8 billion in 2022 at a CAGR of 7.0% for the period 2017-2022.
Table of Contents
1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Related Research Reports
4 Anti-Parkinson's Drugs Market Size and Growth
- Historic Market Growth
- Drivers of the Market
- Restraints on the Market
- Forecast Market Growth
- Drivers of the Market
- Restraints on the Market
5 Anti-Parkinson's Drugs Market Trends and Strategies
- New Medication to Help the Body Absorb Parkinson’s Disease Medication
- Free Water Biomarker to Track Changes in Brain
- 3D Printing Technology
6 PESTLE Analysis
- Political
- Government Financial Support
- Uncertain Political Policies
- Government Intervention
- Economic
- Wealth
- Globalization
- Emerging Markets
- Social
- Aging Global Population
- Health Consciousness and Awareness
- Traditional Medicine Continues to Pose Threat to Market
- Shortage of Skill
- Technological
- Technological Breakthroughs
- Wearable Technology and Hardware Advancements
- Internet Penetration and Mobile Applications
- Legal
- Stringent Regulations and Long Approval Procedures
- Tax Exemptions Initiatives and Subsidies
- Investment Regulations
- Environmental
7 Anti-Parkinson's Drugs Market Segmentation
- Global Anti-Parkinson's Drugs Market, by Segment
- Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
- Dopaminergics Market
- Market Characteristics
- Market Trends and Strategies
- Dopamine Agonists Market
- Market Characteristics
- Market Trends and Strategies
- Enzyme Inhibitors Market
- Market Characteristics
- Market Trends and Strategies
- Other Anti-Parkinson's Medications Market
- Market Characteristics
8 Anti-Parkinson's Drugs Market Regional and Country Analysis
- Global Anti-Parkinson's Drugs Market, by Region
- Global Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Region
- Global Anti-Parkinson's Drugs Market Segmentation, by Region, 2017
- Global Anti-Parkinson's Drugs Market, by Country
- Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Country
- Global Anti-Parkinson's Drugs Market Segmentation, 2017, by Country
9 Global Anti-Parkinson's Drugs Market Comparison with Macro Economic Factors
- Global Per Capita Average Anti-Parkinson's Drugs Market Expenditure
- Per Capita Average Anti-Parkinson's Drugs Market Expenditure, by Country
10 Asia-Pacific Anti-Parkinson's Drugs Market
- Asia-Pacific Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Export and Import Duties on Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- Asia-Pacific Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Asia-Pacific Anti-Parkinson's Drugs Market Forecast Market
- Asia-Pacific Anti-Parkinson's Drugs Market, by Segment
- Asia-Pacific Anti-Parkinson's Drugs Market, Historic and Forecast CAGR, by Segment
11 Asia-Pacific Anti-Parkinson's Drugs Market: Country Analysis
- China Anti-Parkinson's Drugs Market Overview
- Country Information
- Market information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Export and Import Duties on Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- China Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- China Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- China Market Size, by Segment
- China Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- India Anti-Parkinson's Drugs Market Overview
- Country Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Import and Export Duties
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- India Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- India Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- India Market Size, by Segment
- India Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- Japan Anti-Parkinson's Drugs Market Overview
- Country Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Import and Export Duties on Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- Japan Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Japan Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- Japan Market Size, by Segment
- Japan Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- Australia Anti-Parkinson's Drugs Market
- Australia Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Australia Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- Australia Market Size, by Segment
- Australia Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
12 Western Europe Anti-Parkinson's Drugs Market
- Western European Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- Western Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
- Western Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Western Europe Market Size, by Segment
- Western Europe Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
13 Western Europe Anti-Parkinson's Drugs Market: Country Analysis
- UK Anti-Parkinson's Drugs Market Overview
- Country Information
- Market information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Export and Import Duties on Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- UK Anti-Parkinson's Drugs Historic Market, 2013-2017
- UK Anti-Parkinson's Drugs Forecast Market, 2017-2022
- UK Market Size, by Segment
- UK Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- Germany Anti-Parkinson's Drugs Market
- Germany Anti-Parkinson's Drugs Historic Market, 2013-2017
- Germany Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Germany Market Size, by Segment
- Germany Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- France Anti-Parkinson's Drugs Market
- France Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- France Anti-Parkinson's Drugs Forecast Market, 2017-2022
- France Market Size, by Segment
- France Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
- Italy Anti-Parkinson's Drugs Market
- Italy Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Italy Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- Italy Market Size, by Segment
- Italy Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022,
- Spain Anti-Parkinson's Drugs Market
- Spain Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Spain Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Spain Market Size, by Segment
- Spain Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
14 Eastern Europe Anti-Parkinson's Drugs Market
- Eastern European Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Export and Import Duties On Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- Eastern Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
- Eastern Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Eastern Europe Market Size, by Segment
- Eastern Europe Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
15 Eastern Europe Anti-Parkinson's Drugs Market: Country Analysis
- Russia Anti-Parkinson's Drugs Market
- Russia Anti-Parkinson's Drugs Historic Market, 2013-2017
- Russia Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Russia Market Size, by Segment
- Russia Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
16 North America Anti-Parkinson's Drugs Market
- North America Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- North America Anti-Parkinson's Drugs Historic Market, 2013-2017
- North America Anti-Parkinson's Drugs Forecast Market, 2017-2022
- North America Market Size, by Segment
- North America Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
17 North America Anti-Parkinson's Drugs Market: Country Analysis
- USA Anti-Parkinson's Drugs Market
- USA Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- USA Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- USA Market Size, by Segment
- USA Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
18 South America Anti-Parkinson's Drugs Market
- South America Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- South America Anti-Parkinson's Drugs Historic Market, 2013-2017
- South America Anti-Parkinson's Drugs Forecast Market, 2017-2022
- South America Market Size, by Segment
- South America Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
19 South America Anti-Parkinson's Drugs Market: Country Analysis
- Brazil Anti-Parkinson's Drugs Market
- Brazil Anti-Parkinson's Drugs Historic Market, 2013-2016
- Brazil Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- Brazil Market Size, by Segment
- Brazil Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
20 Middle East Anti-Parkinson's Drugs Market
- Middle Anti-Parkinson's Drugs Market Overview
- Region Information
- Market information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulations
- Regulatory Bodies
- Major Associations
- Competitive Landscape
- Middle East Anti-Parkinson's Drugs Historic Market, 2013-2017
- Middle East Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Middle East Market Size, by Segment
- Middle East Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
21 Africa Anti-Parkinson's Drugs Market
- Africa Anti-Parkinson's Drugs Market Overview
- Region Information
- Market information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Regulatory Bodies
- Major Associations
- Export and Import Duties on Anti-Parkinson Drugs
- Competitive Landscape
- Africa Anti-Parkinson's Drugs Historic Market, 2013-2017
- Africa Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Africa Market Size, by Segment
- Africa Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
22 Anti-Parkinson's Drugs Market Customer Information
- Significant Impact of Parkinson's Disease on Quality of Life
- Knowledge Gaps among Parkinson's Patients and Caregivers
- Parkinson's Awareness in UK
- Knowledge on Parkinson's Disease among Patients and General Neurologists
- Power of Placebo
23 Anti-Parkinson's Drugs Market Competitive Landscape
- Company Profiles
- ABBVIE
- BOEHRINGER INGELHEIM
- F. HOFFMANN-LA ROCHE AG
- NOVARTIS AG
- UCB SA
24 Key Mergers and Acquisitions in the Anti-Parkinson's Drugs Market
- Teva Pharmaceutical Acquired Auspex Pharmaceuticals
- Mitsubishi Tanabe Acquired NeuroDerm
- Sunovion Pharmaceuticals Acquired Cynapsus Therapeutics
- Acorda Therapeutics Acquired Civitas Therapeutics
- Acorda Therapeutics Acquired Biotie Therapies
25 Appendix
- Definitions of the Industry
- Anti-Parkinson's Drugs
- Research Methodology
List of Tables:
Summary Table: Global Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 1: Global Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 2: Global Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 3: Global Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 4: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 5: Global Anti-Parkinson’s Drugs Market, by Region, 2017
Table 6: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Region, 2013-2022
Table 7: Global Anti-Parkinson’s Drugs Market Segmentation, by Region, 2017
Table 8: Global Anti-Parkinson’s Drugs Market, by Country, 2017
Table 9: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Country, 2013-2022
Table 10: Global Anti-Parkinson’s Drugs Market Segmentation, by Country, 2017
Table 11: Global Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, 2013-2022
Table 12: Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, by Country, 2017
Table 13: Asia-Pacific-Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 14: Asia-Pacific Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 15: Asia-Pacific Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 16: Asia-Pacific Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 17: China Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 18: China Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 19: China Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 20: China Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 21: India Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 22: India Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 23: India Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 24: India Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 25: Japan Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 26: Japan Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 27: Japan Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 28: Japan Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 29: Australia Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 30: Australia Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 31: Australia Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 32: Australia Anti-Parkinson’s Drugs Market Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 33: Western Europe Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 34: Western Europe Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 35: Western Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 36: Western Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 37: UK Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 38: UK Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 39: UK Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 40: UK Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 41: Germany Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 42: Germany Anti-Parkinson’s Drugs Forecast Market, Through 2022,
Table 43: Germany Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 44: Germany Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 45: France Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 46: France Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 47: France Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 48: France Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 49: Italy Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 50: Italy Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 51: Italy Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 52: Italy Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 53: Spain Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 54: Spain Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 55: Spain Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 56: Spain Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 57: Eastern Europe Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 58: Eastern Europe Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 59: Eastern Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 60: Eastern Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 61: Russia Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 62: Russia Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 63: Russia Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 64: Russia Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 65: North America Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 66: North America Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 67: North America Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 68: North America Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 69: USA Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 70: USA Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 71: USA Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 72: USA Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 73: South America Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 74: South America Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 75: South America Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 76: South America Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 77: Brazil Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 78: Brazil Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 79: Brazil Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 80: Brazil Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 81: Middle East Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 82: Middle East Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 83: Middle East Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 84: Middle East Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 85: Africa Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 86: Africa Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 87: Africa Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 88: Africa Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 89: Global Market Share for Key Competitors of Anti-Parkinson’s Drugs, 2017
Table 90: AbbVie, Inc.: Financial Performance, 2013-2017
Table 91: Boehringer Ingelheim: Financial Performance, 2013-2016
Table 92: F. Hoffmann-La Roche: Financial Performance, 2013-2017
Table 93: Novartis AG: Financial Performance, 2013-2017
Table 94: UCB SA: Financial Performance, 2013-2017
Table 95: Market Data Sources
Table 1: Global Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 2: Global Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 3: Global Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 4: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 5: Global Anti-Parkinson’s Drugs Market, by Region, 2017
Table 6: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Region, 2013-2022
Table 7: Global Anti-Parkinson’s Drugs Market Segmentation, by Region, 2017
Table 8: Global Anti-Parkinson’s Drugs Market, by Country, 2017
Table 9: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Country, 2013-2022
Table 10: Global Anti-Parkinson’s Drugs Market Segmentation, by Country, 2017
Table 11: Global Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, 2013-2022
Table 12: Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, by Country, 2017
Table 13: Asia-Pacific-Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 14: Asia-Pacific Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 15: Asia-Pacific Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 16: Asia-Pacific Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 17: China Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 18: China Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 19: China Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 20: China Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 21: India Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 22: India Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 23: India Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 24: India Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 25: Japan Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 26: Japan Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 27: Japan Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 28: Japan Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 29: Australia Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 30: Australia Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 31: Australia Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 32: Australia Anti-Parkinson’s Drugs Market Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 33: Western Europe Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 34: Western Europe Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 35: Western Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 36: Western Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 37: UK Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 38: UK Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 39: UK Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 40: UK Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 41: Germany Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 42: Germany Anti-Parkinson’s Drugs Forecast Market, Through 2022,
Table 43: Germany Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 44: Germany Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 45: France Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 46: France Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 47: France Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 48: France Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 49: Italy Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 50: Italy Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 51: Italy Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 52: Italy Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 53: Spain Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 54: Spain Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 55: Spain Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 56: Spain Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 57: Eastern Europe Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 58: Eastern Europe Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 59: Eastern Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 60: Eastern Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 61: Russia Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 62: Russia Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 63: Russia Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 64: Russia Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 65: North America Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 66: North America Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 67: North America Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 68: North America Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 69: USA Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 70: USA Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 71: USA Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 72: USA Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 73: South America Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 74: South America Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 75: South America Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 76: South America Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 77: Brazil Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 78: Brazil Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 79: Brazil Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 80: Brazil Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 81: Middle East Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 82: Middle East Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 83: Middle East Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 84: Middle East Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 85: Africa Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 86: Africa Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 87: Africa Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 88: Africa Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 89: Global Market Share for Key Competitors of Anti-Parkinson’s Drugs, 2017
Table 90: AbbVie, Inc.: Financial Performance, 2013-2017
Table 91: Boehringer Ingelheim: Financial Performance, 2013-2016
Table 92: F. Hoffmann-La Roche: Financial Performance, 2013-2017
Table 93: Novartis AG: Financial Performance, 2013-2017
Table 94: UCB SA: Financial Performance, 2013-2017
Table 95: Market Data Sources
List of Figures:
Summary Figure: Global Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 1: Global Anti-Parkinson's Drugs Historic Market, 2013-2017
Figure 2: Global Anti-Parkinson's Drugs Forecast Market, 2017-2022
Figure 3: PESTLE Analysis: Global Anti-Parkinson’s Drugs Market, 2017
Figure 4: Global Anti-Parkinson’s Drugs Market Share, by Segment, 2017
Figure 5: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 6: Global Anti-Parkinson’s Drugs Market Share, by Region, 2017
Figure 7: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Region, 2013-2022
Figure 8: Global Anti-Parkinson’s Drugs Market Segmentation, by Region, 2017,
Figure 9: Global Anti-Parkinson’s Drugs Market Share, by Country, 2017
Figure 10: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Country, 2013-2022
Figure 11: Global Anti-Parkinson’s Drugs Market Segmentation, by Country, 2017
Figure 12: Global Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, 2013-2022
Figure 13: Asia-Pacific Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 14: Asia-Pacific Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 15: Asia-Pacific Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 16: Asia-Pacific Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 17: China Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 18: China Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 19: China Anti-Parkinson’s Drugs Market Share, by Segment, 2017
Figure 20: China Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 21: India Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 22: India Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 23: India Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 24: India Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 25: Japan Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 26: Japan Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 27: Japan Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 28: Japan Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 29: Australia Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 30: Australia Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 31: Australia Anti-Parkinson’s Drugs Market Share, by Segment, 2017
Figure 32: Australia Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 33: Western Europe Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 34: Western Europe Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 35: Western Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 36: Western Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 37: UK Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 38: UK Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 39: UK Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 40: UK Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 41: Germany Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 42: Germany Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 43: Germany Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 44: Germany Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 45: France Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 46: France Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 47: France Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 48: France Anti-Parkinson’s Drugs Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 49: Italy Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 50: Italy Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 51: Italy Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 52: Italy Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 53: Spain Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 54: Spain Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 55: Spain Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 56: Spain Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 57: Eastern Europe Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 58: Eastern Europe Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 59: Eastern Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 60: Eastern Europe Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 61: Russia Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 62: Russia Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 63: Russia Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 64: Russia Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 65: North America Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 66: North America Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 67: North America Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 68: North America Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 69: USA Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 70: USA Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 71: USA Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 72: USA Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 73: South America Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 74: South America Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 75: South America Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 76: South America Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 77: Brazil Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 78: Brazil Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 79: Brazil Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 80: Brazil Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 81: Middle East Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 82: Middle East Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 83: Middle East Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 84: Middle East Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 85: Africa Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 86: Africa Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 87: Africa Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 88: Africa Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 89: Global Market Share for Key Competitors of Anti-Parkinson’s Drugs, 2017,
Figure 90: AbbVie Inc.: Financial Performance, 2013-2017
Figure 91: Boehringer Ingelheim: Financial Performance, 2013-2016
Figure 92: F. Hoffmann-La Roche: Financial Performance, 2013-2017
Figure 93: Novartis AG: Financial Performance, 2013-2017
Figure 94: UCB SA: Financial Performance, 2013-2017
Figure 1: Global Anti-Parkinson's Drugs Historic Market, 2013-2017
Figure 2: Global Anti-Parkinson's Drugs Forecast Market, 2017-2022
Figure 3: PESTLE Analysis: Global Anti-Parkinson’s Drugs Market, 2017
Figure 4: Global Anti-Parkinson’s Drugs Market Share, by Segment, 2017
Figure 5: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 6: Global Anti-Parkinson’s Drugs Market Share, by Region, 2017
Figure 7: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Region, 2013-2022
Figure 8: Global Anti-Parkinson’s Drugs Market Segmentation, by Region, 2017,
Figure 9: Global Anti-Parkinson’s Drugs Market Share, by Country, 2017
Figure 10: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Country, 2013-2022
Figure 11: Global Anti-Parkinson’s Drugs Market Segmentation, by Country, 2017
Figure 12: Global Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, 2013-2022
Figure 13: Asia-Pacific Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 14: Asia-Pacific Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 15: Asia-Pacific Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 16: Asia-Pacific Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 17: China Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 18: China Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 19: China Anti-Parkinson’s Drugs Market Share, by Segment, 2017
Figure 20: China Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 21: India Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 22: India Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 23: India Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 24: India Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 25: Japan Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 26: Japan Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 27: Japan Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 28: Japan Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 29: Australia Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 30: Australia Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 31: Australia Anti-Parkinson’s Drugs Market Share, by Segment, 2017
Figure 32: Australia Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 33: Western Europe Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 34: Western Europe Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 35: Western Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 36: Western Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 37: UK Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 38: UK Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 39: UK Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 40: UK Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 41: Germany Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 42: Germany Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 43: Germany Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 44: Germany Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 45: France Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 46: France Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 47: France Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 48: France Anti-Parkinson’s Drugs Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 49: Italy Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 50: Italy Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 51: Italy Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 52: Italy Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 53: Spain Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 54: Spain Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 55: Spain Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 56: Spain Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 57: Eastern Europe Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 58: Eastern Europe Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 59: Eastern Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 60: Eastern Europe Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 61: Russia Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 62: Russia Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 63: Russia Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 64: Russia Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 65: North America Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 66: North America Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 67: North America Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 68: North America Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 69: USA Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 70: USA Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 71: USA Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 72: USA Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 73: South America Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 74: South America Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 75: South America Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 76: South America Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 77: Brazil Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 78: Brazil Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 79: Brazil Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 80: Brazil Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 81: Middle East Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 82: Middle East Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 83: Middle East Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 84: Middle East Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 85: Africa Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 86: Africa Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 87: Africa Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 88: Africa Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 89: Global Market Share for Key Competitors of Anti-Parkinson’s Drugs, 2017,
Figure 90: AbbVie Inc.: Financial Performance, 2013-2017
Figure 91: Boehringer Ingelheim: Financial Performance, 2013-2016
Figure 92: F. Hoffmann-La Roche: Financial Performance, 2013-2017
Figure 93: Novartis AG: Financial Performance, 2013-2017
Figure 94: UCB SA: Financial Performance, 2013-2017
Samples
LOADING...
Companies Mentioned
- ABBVIE
- BOEHRINGER INGELHEIM
- F. Hoffmann-La Roche AG
- NOVARTIS AG
- UCB SA